Human immune response to SARS-CoV-2: What is known? A scoping review

Rodriguez, Ivon Johanna; Chamucero Millares, Julián; Lalinde Ruiz, Nicolás; Llano León, Manuela; Martínez Enríquez, Laura; Montilla Velásquez, María del Pilar; Rodríguez Bohórquez, Oscar Mauricio; Velandia Vargas, Esteban Alejandro; Parra López, Carlos Alberto.
Infectio ; 24(3,supl.1): 26-35, oct.-dic. 2020. tab, graf
Artículo en Inglés | LILACS, COLNAL | ID: biblio-1143095

Documentos relacionados

  1. Challenges and opportunities in long COVID research.
  2. Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab.
  3. Host Recovery from Respiratory Viral Infection.
  4. A critical review on brain and heart axis response in COVID-19 patients: Molecular mechanisms, mediators, biomarkers, and therapeutics.
  5. Potential biomarkers for the early prediction of SARS-COV-2 disease outcome.
  6. Proteomic characteristics of the treatment trajectory of patients with COVID-19.
  7. COVID-19-neutralizing antibodies predict disease severity and survival.
  8. Differentially-regulated miRNAs in COVID-19: A systematic review.
  9. Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID-19 patients: A meta-analysis.
  10. Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil.